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Background: With the increase in the number of genome sequencing projects, there is a concomitant exponential growth in the
number of protein sequences whose function is still unknown. Functional proteomics constitutes an emerging research area in
the proteomic field whose approaches are addressed towards two major targets: the elucidation of the biological function of
unknown proteins and the definition of cellular mechanisms at the molecular level.
Methods: The identification of interacting proteins in stable complexes in vivo is essentially achieved by affinity-based
procedures. The basic idea is to express the protein of interest with a suitable tag to be used as a bait to fish its specific partners
out from a cellular extract. Individual components within the multi-protein complex can then be identified by mass
spectrometric methodologies.
Results and conclusions: The association of an unknown protein with partners belonging to a specific protein complex
involved in a particular mechanism is strongly suggestive of the biological function of the protein. Moreover, the identification
of protein partners interacting with a given protein will lead to the description of cellular mechanisms at the molecular level.
The next goal will be to generate animal models bearing a tagged form of the bait protein.
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As the human genome sequencing project came to
a successful end, it appeared immediately clear that
the knowledge of the entire DNA sequence of an
organism certainly represented a wealth of informa-
tion but constituted more a starting point than the
bend of the storyQ in understanding the function of
living cells at the molecular level. In the last years,
the challenge has then shifted to the protein side,57 (2005) 140–150
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aims of identifying and localising proteins within a
given organelle, cell, or even organism, as well as
unraveling protein pathways in vivo [1–8]. These
new goals, however, cannot be easily achieved as
intrinsic difficulties increase by several orders of
magnitude when moving from genome to proteome
research. The static nature of the genome, in fact,
cannot be compared to the dynamic properties of the
proteome; protein expression profiles change several
times during the cell cycle and are heavily affected
by a number of intracellular and extracellular stimuli
(temperature, stress, apoptotic signals, etc.) [1].
Moreover, the occurrence of alternative splicing
and post-translational modifications led to a com-
plete rethinking of the old paradigm bone gene–one
protein,Q which does not reflect anymore the real
nature of the cellular proteome.
Current proteome investigations are essentially fo-
cused on two major areas: expression proteomics,
which aims to measure the up-regulation and down-
regulation of protein levels, and functional proteo-
mics, which aims to characterise protein activities,
multiprotein complexes, and signaling pathways [9–
12]. Typically, expression proteomics studies are
addressed to the investigation of the expression pro-
tein patterns in abnormal cells (i.e., malignant, stim-
ulated by drug treatment, etc.), in comparison with
normal cells. In biomedical application, this compar-
ative approach is usually employed to identify pro-
teins that are upregulated or downregulated in a
disease-specific manner for use as diagnostic markers
or therapeutic targets [13–16]. In these studies, a
reliable analysis of quantitative changes in protein
expression is crucial. Such changes are often obtained
from the staining intensities of protein spots on gels, a
labor-intensive method that is prone to error. Recently,
better and more reliable results were achieved using
stable isotope methodologies or dual fluorescent tech-
niques [17–20].
Functional proteomics constitutes an emerging
research area in the proteomic field that is bfocused
to monitor and analyse the spatial and temporal
properties of the molecular networks and fluxes in-
volved in living cellsQ [1]. With the increase in the
number of genome sequencing projects that are
being carried out, there is a concomitant exponential
growth in the number of protein sequences whosefunction is still unknown. Biological sciences are
then experiencing a sort of paradoxical situation in
which the protein sequence, the corresponding cod-
ing gene, its chromosomic localization, or even the
regulation mechanisms may have been elucidated,
but the biological role of the protein in the cell is
still completely obscure.
Functional proteomics approaches are addressed
towards two major targets: the elucidation of biolog-
ical functions of unknown proteins and the definition
of cellular mechanisms at the molecular level. In the
cells, many proteins display their biological functions
through the rapid and transient association within
large protein complexes [21]. Understanding protein
functions as well as unraveling molecular mechanisms
within the cell then depend on the identification of the
interacting protein partners. The association of an
unknown protein with partners belonging to a specific
protein complex involved in a particular mechanism
would, in fact, be strongly suggestive of its biological
function [22,23]. Furthermore, a detailed description
of the cellular signaling pathways might greatly ben-
efit from the elucidation of protein–protein interac-
tions in vivo [24].2. Protein identification by mass spectrometry
methodologies
The identification of proteins fractionated by either
1D or 2D gel electrophoresis is essentially obtained
through peptide mass fingerprinting using MALDI-
MS (Fig. 1). Proteins are excised from the gel, re-
duced and alkylated with iodoacetamide to irrevers-
ibly block the cysteine residues, and digested in situ
with trypsin. The resulting peptide mixture is then
directly analysed by MALDI-MS using a reflectron
instrument. Identification of the various proteins is
carried out through the peptide mass fingerprinting
procedure: the mass values, together with other infor-
mation, such as the protease used for the hydrolysis
and the protein molecular mass roughly estimated
from the SDS PAGE gel, are introduced into different
mass search programs (ProFound, Mascot, MS-Fit,
etc.) available on the net. The mass values are com-
pared to those originated from the theoretical diges-
tion of all the proteins occurring in the database,
leading to the identification of the protein(s).
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Fig. 1. Outline of protein identification strategy by peptide mass fingerprinting.
M. Monti et al. / Clinica Chimica Acta 357 (2005) 140–150142Alternatively, when the mass fingerprinting proce-
dure is not sufficient to identify the proteins, liquid
chromatography coupled to tandem mass spectrome-
try (LC-MS/MS) methods can be employed (Fig. 2).
Peptide mixtures produced by in situ digestions are
fractionated by capillary HPLC analysis, the fractionseluted from the column are directly inserted into the
ES mass spectrometry source, and their mass values
are determined. Peptide ions will simultaneously be
isolated and fragmented within the mass spectrometer,
producing daughter ion spectra from which sequence
information on individual peptides can be obtained.
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Fig. 2. Schematic description of protein identification performed by the LC-MS/MS approach.
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databases, leading to the identification of the protein
components.Table 1
Affinity tags and ligands commonly used in the isolation of multi
protein complexes
Tag Ligand
Poly-His Ni++
Biotin Streptavidin
Calmodulin-binding peptide Calmodulin (Ca++
GST Glutathione
Specific epitope (FLAG, c-myc, HA, etc.) Monoclonal Ab3. Identification of protein partners by functional
proteomics approaches
The identification of interacting proteins in stable
complexes in vivo essentially relies on affinity-based
procedures. The basic idea is to express the protein of
interest with a suitable tag to be used as a bait to fish
its specific partners out from a cellular extract. Isola-
tion of the entire multi-protein complex can then be
accomplished by taking advantage of the availability
of several anti-tag systems, immobilised on agarose–
sepharose supports, and by showing high binding
efficiency, as illustrated in Table 1 [25]. Different
strategies relying on this simple concept have been
developed and a brief overview of the main
approaches presently used in functional proteomics
studies is described below.3.1. Fishing for partners’ strategies
Using commercially available protein expression
systems, the protein bait can be produced as a hybrid
protein fused to the glutathione S-transferase (GST-
fused protein) or to small peptide epitopes (i.e.,
FLAG, HA, or c-myc), or containing a poly-His tail,
or covalently modified with biotin. In all cases, the
tagged bait can be immobilised onto agarose beads
derivatised with the appropriate anti-tag ligand (glu-
tathione, anti-epitope antibodies, nickel ions, strepta-
vidin, etc.). All these affinity tag systems provided a-
)
Protein Bait Specific ligand
on beads
Bait linked to the 
beads
Specific
Interactions
Cellular extract incubated with 
the immobilised bait
Unbound proteins
Elution of bait and partner(s)
SDS-PAGE separation
and in situ hydrolysis 
Fishing for Partners Strategy
MS Identification
Fig. 3. Outline of the bfishing for partnersQ strategy.
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and a minimal effect on the tertiary structure and
biological activity of the bait, preventing complexes’
instability. The entire cellular extract and/or, when
appropriate, the extract from specific organelles can
then be incubated with the immobilised bait. The
immobilised protein forms stable non-covalent inter-
actions with specific partners occurring in the cellular
extract, whereas the unbound proteins will be eluted
during the washing. The protein components specifi-
cally recognised by the bait and retained on the aga-
rose beads can then be eluted and fractionated byZNF224-WT
I     II      III    IV    V     
ZNF224-M4
KRAB 
Domain
6 47
ZnF224 pr
Fig. 4. Schematic structure of the zinc finger ZnF224 protein and its delSDS-PAGE. The protein bands detected on the gel
are in situ enzymatically digested and the resulting
peptide mixtures are analysed by MALDI/MS finger-
printing and/or LC-MS/MS techniques, leading to the
identification of the proteins by database search. An
outline of this approach is shown in Fig. 3.
This strategy was applied to the identification of
the protein partners of ZnF224, a zinc-finger protein
of about 82 kDa belonging to the bKru¨ppel-likeQ zinc-
finger proteins family (KRAB-ZFPs), one of the larg-
est classes of transcription factors (Fig. 4) [26].
ZnF224 specifically binds to the negative regulatoryVI    VII  VIII  IX      X    XI   XII  XIII  XIV  XV  XVI XVII XVIII XIX 
Zinc finger domains
otein
etion mutant ZnF224-M4, lacking the last 15 zinc-finger domains.
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of the human aldolase A gene through its array of zinc
fingers and inhibits the transcription by the 45-amino-
acid KRAB-A domain. The proteins interacting with
ZnF224 and involved in the transcriptional inhibition,
as well as the molecular mechanisms of these negative
regulation processes, are still unknown. In order to
elucidate these aspects, the full-length cDNAs of
ZnF224 and its deletion mutant ZnF224-M4 contain-
ing only four zinc fingers were expressed as fused
protein to the C-terminus of GST and purified on
glutathione–sepharose resin. The purified chimeric
bait was then linked to GSH-activated beads.
Nuclear 293 cell extracts were pre-purified by
incubation with beads treated with GST alone in
order to get rid of both matrix and GST-interacting
proteins and to obtain a higher cleaning of the
protein mixture. The pre-cleaned extract was then
incubated with the GST-ZnF224 bait. After several
washings to remove unbound proteins, the complex
components were eluted from the beads, separated
by SDS-PAGE, and stained with colloidal Coomas-
sie. The resulting gel pattern is shown in Fig. 5; the
poor quality of these results is strongly indicative of
the limitations of this procedure, as discussed below.The ZnF224-M4 protein partners
250
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Fig. 5. SDS-PAGE analysis of the GST pulldown experiment
carried out using GST-ZnF224-M4 as bait with pre-cleaning steps.
Lane M: markers; lane 1: proteins bound to GST-M4; lane 2:
unretained proteins; lane 3: proteins bound to GST alone.The occurrence of an excessive background, the
presence of several identical bands in both the sam-
ple and the control, and the difficulties in identifying
the proteins specifically interacting with the bait
immediately underline the need to optimize sample
cleaning procedures. Protein bands indicated by
arrows appeared to be present only in the sample
and were then selected for identification by in situ
digestion and LC-MS/MS analysis.
Although this approach has found large applica-
tions in the studies of protein–protein interactions, a
conspicuous number of drawbacks exist. As men-
tioned above, extensive pre-cleaning of the extract is
needed and a number of control samples have to be
prepared. Moreover, when protein extracts are pre-
pared by cellular lysis, the architecture of the subcel-
lular compartments is disrupted and proteins that are
normally segregated in different organelles can come
in contact, generating nonphysiological interactions.
However, the major criticism to this approach is that
all the interactions among the bait and its protein
partners are essentially in vitro interactions taking
place outside the cell, on the derivatised beads.
These drawbacks might originate a number of false
positives that should be considered when using these
procedures.
The success of an affinity-based approach then
depends on the absence of excessive aspecific inter-
actions, which in turn is related to the specificity of
the bait partners recognition. When this binding spec-
ificity is extremely high, as in the case of DNA-
binding proteins, very good results can be achieved.
In this particular variant of the fishing strategy, the
bait consists of a specific oligonucleotide linked to an
insoluble support. Nuclear proteins can then be incu-
bated with the bait in search for specific partners,
following the strategy outlined above [27]. Control
experiments can easily be designed using randomised
oligonucleotides. This strategy was applied to the
identification of the transcriptional repressor that spe-
cifically binds to the human aldolase A (AldA) neg-
ative regulatory element (NRE). This factor was
eventually identified as the ZnF224 protein [26].
It is important to underline that when a putative
candidate is provided by proteomic approaches, this
identification has to be confirmed by independent
methodologies. In the case of ZnF224, the ability
to recognise both its specific DNA binding site and
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A gene expression had to be tested. Therefore, a
band shift experiment with the AldA-NRE oligonu-
cleotide region was carried out using the recombi-
nant form of the wild type protein and two deletion
mutants. Moreover, to test the ZNF224-mediated
transcriptional repression, a classical CAT reporter
gene assay was developed using the recombinant
plasmid encoding ZNF224. The expressed ZNF224
protein negatively modulated the reporter CAT gene
transcription in a dose-dependent manner. These
results demonstrated that indeed ZnF224 was able
to specifically recognise the DNA target and to
repress AldA-NRE-mediated transcription of a heter-
ologous promoter [26].
3.2. Immunoprecipitation strategies
To overcome most of the drawbacks affecting the
affinity-based approaches, alternative strategies essen-Interaction Pr
Immunoprecipit
Immun
precipitatat
protein com
Fractionation
on 1-D gel
Protein
identifica
by MS
Transfe
into c
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expressing
epitope-tagged
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Fig. 6. Outline of the immuntially relying on immunoprecipitation techniques have
been introduced [28]. An outline of these strategies is
reported in Fig. 6. The gene coding for the bait tagged
with an epitope against which good antibodies exist
(FLAG, HA, c-myc, etc.) is transfected into the ap-
propriate cell line and expressed in the cognate host.
Protein complexes are allowed to form in vivo within
the cell and the cell extracts are immunoprecipitated
with anti-tag monoclonal antibodies using suitable
experimental conditions to avoid dissociation of the
complexes. The immunoprecipitated material contain-
ing the protein bait and its interacting partners can
then be fractionated by SDS-PAGE and the individual
protein components identified by different mass spec-
trometric methodologies.
The immunoprecipitation strategy was employed
to identify the protein partners of FCP1, a conserved
phosphatase involved in the regulation of eukaryotic
RNA polymerase II [29]. RNA polymerase II is
subjected to reversible phosphorylation of the C-oteomics by
ation Methods
bait
o-
ion of
plexes
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ells
100
m/z0
oprecipitation strategy.
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the transcription cycle. While several kinases affect
the CTD phosphorylation status during transcription,
FCP1 protein is the only CTD phosphatase identified
so far [30,31]. In order to elucidate the role of FCP1,
a biochemical characterization of FCP1 associating
factors using a 3xFLAG-tagged FCP1 stably expres-
sing cell line was performed [32]. Following com-
plex formation, nuclear extracts were collected and
immunoprecipitated with anti-FLAG agarose-conju-
gated antibody. The protein bands separated on SDS-
PAGE and stained by colloidal Coomassie were
identified essentially by mass fingerprinting (Fig.
7). Among several other specific FCP1 partners,
the methylosome protein 50, MEP50, was identified.
This protein is involved in the dimethylation of
arginine and belongs to the methylosome complex
located in the cytoplasm, while the FCP1 protein is
exclusively found in the nucleus. Independent veri-
fication experiments were designed, including coim-
munoprecipitation of FLAG-FCP1 and a c-myc-
tagged MEP50 recombinant form and sub-cellular
localization by both sedimentation profiling and im-
munofluorescence techniques. Taken together, theFig. 7. SDS-PAGE analysis of the immunoprecipitation experiment
carried out using 3xFLAG-FCP1 as bait. Lane M: markers; lane 1:
retained proteins specifically bound to 3xFLAG-FCP1.results obtained demonstrated that MEP50 and
FCP1 associate into the nucleus in a complex of
the same size distinct from the 20S methylosome
complex, and that FCP1 is able to interact with
components of the pre-mRNA spliceosomal machin-
ery. These findings add further support to the con-
cept that there is functional intercommunication
between the transcription and splicing machineries,
and the RNAPII-CTD appears to play a pivotal role
in coordinating transcription and pre-mRNA proces-
sing (Refs. [32,33] and references therein).
As described above, identification of protein part-
ners by immunoprecipitation techniques has a num-
ber of advantages over the fishing for partners
approach. However, some negative issues need to
be discussed. Antibodies used in common immunos-
taining methods are not always suitable for immu-
noprecipitation protocols that require a more efficient
(and quantitative) recognition of the proper antigen
compared to Western blot or ELISA applications.
Cross-recognition of aspecific antigens or aspecific
binding of proteins to the antibodies, to the peptide
tags, or to the insoluble agarose support can lead to
false positives. Pre-immunoprecipitation of the cellu-
lar extract with antibodies of the animal host not yet
immunised against the specific antigen is then
strongly suggested.
According to recent literature, the use of antibodies
specifically directed against the protein bait is not
encouraged because the antibody might compete
with the interacting proteins for binding to the bait
epitope, thus leading to destabilization of protein–
protein interactions and dissociation of the protein
complexes, at least partially. The use of tagged pro-
teins has greatly helped to avoid these problems but
has introduced new debated questions. The presence
of the tag can affect protein conformation, thus alter-
ing or impairing complexes formation. Preliminary
experiments with protein baits tagged at either the
N- or the C-terminus should be carried out or, alter-
natively, the three-dimensional structure of the bait,
when available, should carefully be considered to
decide where the tag should be posed. Finally, over-
expression of the tagged protein in the host cells may
definitively alter the stoichiometric ratio between the
bait and the natural partners, often leading to the
formation of nonspecific and/or nonnatural protein
interactions with host proteins [34].
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The tandem affinity purification (TAP) tag system
was developed for the purification of protein com-
plexes in high yield under native conditions [35]. This
method represents an implementation of the tag com-
plexes’ affinity purification procedures described
above, by combining two different tags on the same
protein usually spaced by an enzyme-cleavable linker
sequence. Since the introduction of the original meth-
odology, a number of variant systems have been
proposed. However, the first TAP tag system con-
sisted of two IgG binding domains of Staphylococcus
aureus protein A (ProtA) and a calmodulin binding
peptide (CBP) separated by a TEV protease cleavage
site [36]. Both affinity tags have been selected for
highly efficient recovery of proteins present at low
concentration. However, the system is very flexible
and variations to the original strategy, including ap-
plication of the tag cassette to either the N- or the C-
terminal end of the protein, the introduction of alter-
native tags, and the tailoring of the system for various
host organisms, can easily be obtained.
The N- or C-terminal TAP tags are introduced in-
frame with the coding region of the protein of interest
in an appropriate expression vector using standard
DNA cloning procedures. The tagged construct can
then be transiently or stably introduced into recipient
cells or organisms. Optimally, the recombinant vector
should replace the endogenous wild-type gene, al-
though this condition might not be always possible.
In all cases, overexpression of the protein bait is
avoided since the TAP tag system was specifically
designed for recovery of protein complexes expressed
at their own natural level.
ProtA binds tightly to an IgG matrix, providing the
first affinity purification step of the native complex.
The use of the TEV protease is then required to elute
the bound material under native conditions. The elu-
ant of this first affinity step still containing the intact
complex is then incubated with calmodulin-coated
beads in the presence of calcium. Nonspecific protein
contaminants and the excess of TEV protease are
removed by repetitive washing and the bound material
is released under mild conditions by elution with
EGTA. The released material containing the protein
bait and its interacting partners can then be fraction-
ated by SDS-PAGE and the individual protein com-ponents identified by different mass spectrometric
methodologies.
The introduction of a double affinity purification
procedure significantly reduces the possible occur-
rence of nonspecific protein contaminants, thus de-
creasing both the aspecific background noise on the
SDS gel and the possible presence of false positives.
This method was originally developed in yeast [36]
and has been found in large employment into the
description of multiprotein complexes in Saccharomy-
ces cerevisiae [22]. However, optimized conditions
have been developed for the generic use of the TAP
strategy. Recently, the system has been successfully
optimised even in mammalian cells [37] by using
alternative tags to further reduce aspecific interactions
between tags and extract proteins [38].4. Conclusions and perspectives
Understanding protein function and unraveling cel-
lular mechanisms at the molecular level constitute a
major need in modern biology. With the availability of
full genome sequences, these goals can be achieved
by determining which macromolecules interact with a
given protein in a specific manner. We are witnessing
a scientific period that is reminiscent of the early
1930s when scientists were able to describe bstep by
stepQ the metabolic pathways. For the first time, ex-
perimental procedures are available to define the tran-
sient macromolecular assembly of proteins needed to
fulfill specific and fundamental functions within the
cell, or to design the routes along which signaling
mechanisms can take place. The functional proteomic
approaches described in this paper have proven to be
useful tools for the detection of interacting partners of
a target protein, although each of them highlighted the
occurrence of possible drawbacks. Particular attention
should be paid to attain low levels of false positives,
which might result in misleading interpretations;
improvements and refining of the affinity-based pro-
cedures should take great care of this point. A further
factor that is often neglected is the transient nature of
protein complexes: protein assembly at the right place
and the right time to fulfill a specific function. The
complex then dissociates and individual components
can participate in the formation of other complexes,
following the occurrence of specific signals. Any
M. Monti et al. / Clinica Chimica Acta 357 (2005) 140–150 149attempt to the description of protein interaction net-
works involved in cell functions should carefully con-
sider the dynamics of the formation and dissociation of
protein complexes, as the same protein can interact
with different partners at different times. Finally, the
goal to be pursued in the future will be to transfer these
approaches to real in vivo systems by generating an-
imal models bearing a tagged form of the given pro-
tein. If vital animals are obtained, homozygous
embryos will then provide tissues and/or progenitor
cells for immunoprecipitation assays. Proteomic anal-
yses of the protein complexes occurring in vivo will
disclose the identity of the individual components and
whether they differ from a territory to another.Acknowledgement
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